Table 1.
A | ||
---|---|---|
| ||
Control n=4 |
iNICD n=8 |
|
Heart Rate | 634 ±45 | 473 ±21* |
P wave duration (msec) | 7.61 ±0.34 | 9.35 ±0.53* |
PR (msec) | 33.5 ±1.6 | 36.9 ±1.2 |
QRS (msec) | 9.57 ±0.88 | 11.59 ±0.99 |
B | ||
---|---|---|
| ||
Control n=11 |
iNICD n=14 |
|
Baseline HR | 649 ±21 | 559 ±35 |
Isoproterenol HR (% change) | 728 ±14* (12.1) | 649 ±26† (16.3) |
Atropine HR (% change) | 742 ±6* (14.2) | 676 ±16‡ (21.1) |
Carbachol HR (% change) | 230 ±25§ (64.6) | 227 ±13§ (59.4) |
A. Controls are littermate tetO_NICD mice (n=4 males) and iNICD are αMHC-rtTA; tetO_NICD mice (n=4 females, n=4 males). Both genotypes were fed doxycycline chow at 8 weeks of age for 3 weeks with no washout. EKGs were performed on mice during isoflurane sedation. Statistics were performed using unpaired t tests with Welch’s correction.
P<0.05, data are expressed as mean ± SEM.
B. Controls are littermate αMHC-rtTA mice on dox (n=3 females, n=8 males), and iNICD are experimental αMHC-rtTA; tetO_NICD on dox group (n=8 females, n=6 males). All mice were fed doxycycline chow starting between 2–3 months of age for 3 weeks, followed by a washout period of 2 weeks. EKGs were performed on conscious mice. Adrenergic stimulation with isoproterenol was done by intraperitoneal injection of isoproterenol (0.2 mg/kg), inhibition of parasympathetic activity with atropine (1mg/kg), and carbachol injection was given intraperitoneally (0.3 mg/kg) to simulate increased vagal nerve activity. With repeated measures 2 way ANOVA there is a statistically significant genotype effect F(1,23)=10.6, p=0.0039. There is also a statistically significant drug effect across both genotypes F(3,69)=233.2, P<0.001. However, there is not a significant interaction between drug and genotype F(3,69)=1.739, P=0.17.
P<0.05,
P<0.01,
P<0.001,
P<0.0001, data are expressed as mean ± SEM.